Furthermore, IDH1+ and IDH2+ leukemias differ in their mutational profiles, with high incidence of DNA (cytosine-5)-methyltransferase 3A (DNMT3A) mutations reported in IDH1+, but not IDH2-R140+ AML38,43. This evidence concerns the gene IDH1 and leukemia.